Biomedtech Portfolio

Symetis

Minimaly invasive Aortic Valve

Co-founded by Truffle, Symetis specialised in minimilaly invasive Transcatheter Aortic Valve Implantation (TAVI) devices before being acquired by Boston Scientific for $435 million.

OTHER COMPANIES

Carmat

First-of its kind implantable artificial heart

Evexta Bio

Developing Next Generation Precision Cancer Therapies

Spikimm

SpikImm develops long-acting mAbs to prevent viral infections in imunocompromized patients, in pa...

PK Med

Locally administered therapeutic products to address inflammatory joint diseases and tissue regen...

Skinosive

Bio-adhesive UV filters for long lasting and broad-spectrum sun protection

Caranx Medical

Autonomous robot improving efficiency and safety in Transcatheter Aortic Valve Replacement (TAVI...

BariaTek

Minimally invasive, atraumatic, reversible and endoscopically delivered medical device to treat o...

Artedrone

Autonomous robotic solution to increase the accessibility of mechanical thrombectomy during acute...

Carbios

Biotechnology powering plastic and textile circularity

Affluent Medical

Minimally invasive, biomimetic and adjustable solutions for mitral regurgitation and urinary inco...